REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM NEW
Total 13F shares
22,960,336
Share change
-101,786
Total reported value
$15,856,000
Put/Call ratio
83%
Price per share
$0.69
Number of holders
38
Value change
-$142,911
Number of buys
13
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q3 2021

As of 30 Sep 2021, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,960,336 shares. The largest 10 holders included NEA Management Company, LLC, Endurant Capital Management LP, VANGUARD GROUP INC, VICTORY CAPITAL MANAGEMENT INC, Sarissa Capital Management LP, Asymmetry Capital Management, L.P., Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.